2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $170M | $229M | $261M | $298M | $328M |
Cost of Revenue | $77M | $106M | $126M | $145M | $157M |
Gross Profit | $93M | $123M | $135M | $153M | $171M |
Gross Profit % | 55% | 54% | 52% | 51% | 52% |
R&D Expenses | $37M | $55M | $72M | $72M | $68M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$11M | -$179M | -$104M | -$59M | -$35M |
Dep. & Amort. | $1.4M | $2.4M | $4.3M | $5.1M | $4.9M |
Def. Tax | $4M | $102M | $0 | $0 | $0 |
Stock Comp. | $7.9M | $33M | $67M | $62M | $58M |
Chg. in WC | -$9.3M | -$5.3M | $1.1M | -$19M | -$11M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $104M | $418M | $189M | $441M | $371M |
ST Investments | $14M | $85M | $287M | $34M | $5M |
Cash & ST Inv. | $118M | $503M | $476M | $475M | $376M |
Receivables | $37M | $35M | $38M | $47M | $48M |
Inventory | $6.5M | -$85M | $2.3M | $0 | $0 |
Riskified achieved a 15% GMV growth and 10% revenue growth in 2024, ending the year with $327.5 million in revenue, exceeding the high end of guidance. Adjusted EBITDA for the year was $17.2 million, marking the first full year of positive adjusted EBITDA as a public company.
The company highlighted strong performance in new business and upsell activity, particularly in the tickets, travel, food, and money transfer categories. However, net dollar retention (NDR) declined to 96%, impacted by a churn event in the home category and competitive pressures.
Riskified is focusing on expanding its multi-product platform, with new product revenue up approximately 90% year-over-year in 2024. The company anticipates aggregate revenue in the high single-digit to low double-digit millions from new products like PolicyProtect, Account Secure, and Dispute Resolve in 2025.
For 2025, Riskified provided revenue guidance of $333 million to $346 million and adjusted EBITDA guidance of $18 million to $26 million. The company expects gross profit margins between 52% and 53.5% for the year.
Riskified plans to increase R&D capacity by 20% in 2025 while keeping total expenses flat. The company is also targeting adjusted EBITDA margins of 15%-28% by the end of 2026 and has committed to disciplined capital allocation, including share buybacks and managing share-based compensation.